Clinical Trial Update: The Role of Islet GLP-1 in the Pathogenesis of Prediabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by Mayo Clinic investigating the role of islet GLP-1 in the pathogenesis of prediabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Snippet

Sponsor: Mayo Clinic | Conditions: PreDiabetes | Phase 2 | Status: RECRUITING